A Phase 1 Clinical Trial of AAV2-BDNF Gene Therapy in Alzheimer’s Disease and MCI

Time: 12:30 pm
day: Day One: Track B AM

Details:

  • Prior growth factor gene therapy experience in Alzheimer’s disease
  • Preclinical rationale for translation to the clinic
  • Clinical update

Speakers: